Articles Mentioning Biotechnology Stocks

Results 1 - 10 of 363 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Biotechnology

Investing | July 19, 2016

Is Agenus or Ariad Pharmaceuticals the Better Long-Term Buy?

They're both promising names in the red-hot oncology space. But which stock is the better buy right now?

Investing | June 04, 2016

3 Biotechs Expecting Market-Moving Trial Results Soon

Achillion Pharmaceuticals, Ophthotech Corp., and Kite Pharmaceuticals shares could move wildly because of upcoming trial data.

Investing | May 21, 2016

Here's What Pfizer's Telling Us About Biotech M&A

Pfizer's acquisition of Anacor shows M&A is alive and well for biotech companies with late-stage research programs.

Investing | May 16, 2016

3 Biotech Stocks to Buy in May

On the hunt for a biotech bargain? Our contributors think you should give these stocks a closer look.

Investing | May 04, 2016

Alnylam Pharmaceuticals, Inc.'s Double-Digit "Earnings" Fall

The biotech's numbers are meaningless, but an update on one of its programs sent the stock down.

Investing | May 03, 2016

Regeneron Pharmaceuticals Inc Has a Lot to Prove on May 5

All eyes will be on the biotech behemoth's quarterly report this Thursday.

Investing | April 04, 2016

Better Buy: Regeneron Pharmaceuticals, Inc. vs. Amgen

Can the quick growing maker of Eylea beat an aging biotech behemoth?

Investing | April 03, 2016

This Could Be the Next Big Pharma Buyout

Our healthcare contributors think these five stocks might be on big pharma's shopping list.

Investing | February 11, 2016

This FDA Panel Decision Just Changed the Game

The emergence of biosimilars leads to a shocking FDA panel decision that I guarantee you've never seen before.

Investing | January 30, 2016

AbbVie: There Ain't No Stinkin' Biosimilar Threat

AbbVie's guidance suggests that the threat from biosimilars isn't too scary... at least for now.

Results 1 - 10 of 363 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Biotechnology